Elligo Health Research
PrivateLast Round
Debt
Oct 2, 2023
Total Funding Raised
$201.75M
Company Overview
Elligo Health Research operates in Healthcare & Life Sciences and is based in Austin, Texas. Its latest recorded funding round was a Debt round in October 2023.
Elligo Health Research is a healthcare-enabling research organization that provides clinical trial recruitment, infrastructure, and technology solutions to accelerate the development of pharmaceutical, biotechnology, and medical device products.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Patient Engagement, Healthcare Analytics, Vertical SaaS
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elligo Health Research Comparables
Compare Elligo Health Research with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Care Access | 90% | |
| Circuit Clinical | 87% | |
| Javara Research | 86% |
For institutional investors. Book with your work email.
Elligo Health Research Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Oct 2, 2023 | ||||
| Series E | Sep 23, 2021 | ||||
| Series D | Dec 8, 2020 | ||||
| Grant | Oct 1, 2019 | ||||
| Series C | May 7, 2019 | ||||
Series B | Mar 20, 2018 |
For institutional investors. Book with your work email.
Elligo Health Research Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Morgan Stanley Expansion Capital | Series E |
| Ally Bridge Group | Series E |
| Hatteras Venture Partners | Series E, Series C, Series A, Series B |
| Norwest Venture Partners | Series E |
| Noro-Moseley Partners | Series E, Series C, Series A, Series B |
| Shumway Capital | Series E, Series A, Series B |
| Horizon Technology Finance Corporation | Debt |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 2, 2023
$25M round led by Horizon Technology Finance Corporation.
- Sep 23, 2021
$135M round led by Ally Bridge Group and Morgan Stanley.
For institutional investors. Book with your work email.
Elligo Health Research Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Elligo Health Research's valuation, stock price, and market status.
Is Elligo Health Research a public or private company?
Elligo Health Research is a private company.
What is the current stock price of Elligo Health Research?
Elligo Health Research is a private company, so its shares have no public market price. Caplight tracks Elligo Health Research's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Elligo Health Research worth (valuation)?
Valuation information for Elligo Health Research is not publicly available.
Can I buy Elligo Health Research stock?
Elligo Health Research shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Elligo Health Research's last funding round?
Elligo Health Research's most recent funding round was Debt on October 2, 2023.
Who are the main investors in Elligo Health Research?
Key investors in Elligo Health Research include Morgan Stanley Expansion Capital, Ally Bridge Group, Hatteras Venture Partners, Noro-Moseley Partners, Horizon Technology Finance Corporation.
Will Elligo Health Research IPO soon?
No public IPO plans have been announced for Elligo Health Research.
How can I track Elligo Health Research secondary market activity?
Caplight tracks bids, offers, and trades in Elligo Health Research's shares on secondary markets.